Oxford, MS, United States of America

Xing-Cong Li


Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2006-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Xing-Cong Li

Introduction

Xing-Cong Li is a notable inventor based in Oxford, MS (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-pathogen compositions and antifungal compounds. With a total of 2 patents, his work has the potential to impact the treatment of infectious diseases.

Latest Patents

Li's latest patents include innovative methods for treating infectious diseases. One patent focuses on an anti-pathogen composition that utilizes an active ingredient produced by specific bacteria. This composition aims to provide effective treatment options for various infectious diseases. Another patent involves cyclopentenedione antifungal compounds, which are designed to control, treat, and prevent fungal activity. These compounds are characterized by their unique chemical formula and include stereoisomers, analogs, and pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Xing-Cong Li has worked with esteemed organizations such as the University of Mississippi and Tenfold Technologies LLC. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Li has collaborated with notable colleagues, including Shaohua Guan and Shashi Shankar Rajbanshi. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Xing-Cong Li's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of infectious diseases and fungal infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…